Plain-English translation of NCT07390071 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a multimodal telerehabilitation program — a combination of guided exercise, nutrition planning, education, and behavioral support delivered through an interactive app and web portal — for patients receiving CAR-T cell therapy. CAR-T is an advanced immunotherapy used to treat certain blood cancers like lymphoma and myeloma. The study wants to see whether this program, delivered from home, can help prevent side effects and improve quality of life during and after the medication.
CAR-T cell therapy is very effective against certain blood cancers, but it can cause serious side effects like fatigue, neurological problems, and loss of physical function. Right now, there is no proven home-based support program to help patients stay active and well during this treatment, so this trial is testing whether guided exercise and wellness support can make a real difference.
You likely qualify if…
You likely don't qualify if…
You would start with four weeks of guided prehabilitation (exercise and wellness planning) before your CAR-T treatment begins. During treatment, you would use an interactive app on a tablet or phone to access exercise videos, education, and support while you're in the hospital. After you go home, you would follow a personalized exercise and nutrition plan for 12 weeks, guided by the app and supported by counseling and education from the research team. Throughout, you would have access to a web-based portal to track your progress and stay connected with your care team.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States